characteristics.text: SAMN33717193
characteristics.characteristic: External Id
characteristics.text: dbGaP
characteristics.characteristic: INSDC center name
characteristics.text: 2023-03-11T02:40:48.447Z
characteristics.characteristic: INSDC first public
characteristics.text: 2023-03-31T02:37:48.213Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS17106160
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS17106160
characteristics.characteristic: SRA accession
characteristics.text: DNA
characteristics.characteristic: analyte type
characteristics.text: NCI_LCCC1525_mTNBC
characteristics.characteristic: biospecimen repository
characteristics.text: 102_PBMC_IGH_C2D1
characteristics.characteristic: biospecimen repository sample id
characteristics.text: PBMC
characteristics.characteristic: body site
characteristics.text: phs002659
characteristics.characteristic: gap_accession
characteristics.text: 1
characteristics.characteristic: gap_consent_code
characteristics.text: DS-BRCA-IRB
characteristics.characteristic: gap_consent_short_name
characteristics.text: 5341012
characteristics.characteristic: gap_sample_id
characteristics.text: 4419168
characteristics.characteristic: gap_subject_id
characteristics.text: No
characteristics.characteristic: is tumor
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: female
characteristics.characteristic: sex
characteristics.text: Interventional
characteristics.characteristic: study design
characteristics.text: Triple Negative Breast Neoplasms
characteristics.characteristic: study disease
characteristics.text: Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC
characteristics.characteristic: study name
characteristics.text: Yes
characteristics.characteristic: subject is affected
characteristics.text: 102_PBMC_IGH_C2D1
characteristics.characteristic: submitted sample id
characteristics.text: 102
characteristics.characteristic: submitted subject id
characteristics.text: NCI_LCCC1525_mTNBC
characteristics.characteristic: submitter handle
characteristics.text: Non-tumor DNA sample from PBMC of a human female participant in the dbGaP study Genomics from LCCC1525: A Priming Dose of Cyclophosphamide Prior to Pembrolizumab to Treat mTNBC
characteristics.characteristic: title